Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Non Operating Income (2023 - 2025)

Volitionrx filings provide 3 years of Other Non Operating Income readings, the most recent being -$2.5 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a 2570.09% decrease, with the full-year FY2025 number at -$1.8 million, changed N/A from a year prior.
  • Other Non Operating Income hit -$2.5 million in Q4 2025 for Volitionrx, down from -$308801.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $418681.0 in Q2 2025 to a low of -$2.5 million in Q4 2025.
  • Median Other Non Operating Income over the past 3 years was $129.0 (2024), compared with a mean of -$237874.7.
  • The widest YoY moves for Other Non Operating Income: up 151.53% in 2025, down 239480.62% in 2025.
  • Volitionrx's Other Non Operating Income stood at $60776.0 in 2023, then crashed by 99.79% to $129.0 in 2024, then crashed by 1928690.7% to -$2.5 million in 2025.
  • The last three reported values for Other Non Operating Income were -$2.5 million (Q4 2025), -$308801.0 (Q3 2025), and $418681.0 (Q2 2025) per Business Quant data.